prasugrel tablet film coated
1 INDICATIONS AND USAGE PRASUGREL tablets is a P2Y 12 platelet inhibitor indicated for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI as follows: Patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI) ( 1.1 ). Patients with ST-elevation myocardial infarction (STEMI) when managed with either primary or delayed PCI ( 1.1 ). 1.1 Acute Coronary Syndrome Prasugrel tablet is indicated to reduce the rate of thrombotic cardiovascular (CV) events (including stent thrombosis) in patients with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI) as follows: Patients with unstable angina (UA) or non-ST-elevation myocardial infarction (NSTEMI). Patients with ST-elevation myocardial infarction (STEMI) when managed with primary or delayed PCI. Prasugrel tablet has been shown to reduce the rate of a combined endpoint of cardiovascular death, nonfatal myocardial infarction (MI), or nonfatal stroke compared to clopidogrel. The difference between treatments was driven predominantly by MI, with no difference on strokes and little difference on CV death [see Clinical Studies ( 14 )] .
panacea biotec ltd.
Related Pills
prasugrel 10 mg
panacea biotec ltd.
prasugrel 5 MG Oral Tablet
Panacea Biotec Ltd.
24 HR Glipizide 10 MG Extended Release Oral Tablet
Rising Pharmaceuticals, Inc.
24 HR Glipizide 10 MG Extended Release Oral Tablet
Rising Pharmaceuticals, Inc.
loratadine 10 mg
spirit pharmaceuticals llc
propranolol 10 mg
dispensing solutions, inc.
loratadine 10 mg
spirit pharmaceuticals llc
acetazolamide 500 MG 12 HR Extended Release Capsule
Zydus Pharmaceuticals (USA) Inc.
gabapentin 100 MG Oral Capsule
AvKARE, Inc.
gabapentin 300 MG Oral Capsule
AvKARE, Inc.
APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet
Rebel Distributors Corp
APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet
American Health Packaging
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
PRASUGREL tablet is available as round, biconvex, film- coated, non-scored tablets in the following strengths, colors, imprints, and presentations: Features Strengths 5 mg 10 mg Tablet color yellow beige Tablet imprint 5 10 Tablet imprint P P Presentations and NDC Codes Bottles of 30 43817-239-01 43817-240-01 16.2 Storage and Handling Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP controlled room temperature]. Keep and dispense only in original container. Keep container closed and do not remove desiccant from bottle. Do not break the tablet.
More pills like ROUND P 10